Skip to content

Title 42 — The Public Health and Welfare

Chapter 23 — Development and Control of Atomic Energy

§ 2142. Domestic medical isotope production

Statutory text

(a)

The Commission may issue a license, or grant an amendment to an existing license, for the use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, only if, in addition to any other requirement of this chapter—

(1)

the Commission determines that—

(A)

there is no alternative medical isotope production target that can be used in that reactor; and

(B)

the proposed recipient of the medical isotope production target has provided assurances that, whenever an alternative medical isotope production target can be used in that reactor, it will use that alternative in lieu of highly enriched uranium; and

(2)

the Secretary of Energy has certified that the United States Government is actively supporting the development of an alternative medical isotope production target that can be used in that reactor.

(b)

As used in this section—

(1)

the term “alternative medical isotope production target” means a nuclear reactor target which is enriched to less than 20 percent of the isotope U–235;

(2)

a target “can be used” in a nuclear research or test reactor if—

(A)

the target has been qualified by the Reduced Enrichment Research and Test Reactor Program of the Department of Energy; and

(B)

use of the target will permit the large majority of ongoing and planned experiments and medical isotope production to be conducted in the reactor without a large percentage increase in the total cost of operating the reactor;

(3)

the term “highly enriched uranium” means uranium enriched to 20 percent or more in the isotope U–235; and

(4)

the term “medical isotope” includes molybdenum-99, iodine-131, xenon-133, and other radioactive materials used to produce a radiopharmaceutical for diagnostic or therapeutic procedures or for research and development.

Legislative history

Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.

  1. American Medical Isotopes Production Act of 2012

    Pub. L. 112–239 div. C title XXXI § 3176(a) · 126 Stat. 1632

    Enacted · 42 U.S.C. § 2142

    Aug. 1, 1946, ch. 724, title I, § 112, as added Pub. L. 112–239, div. C, title XXXI, § 3176(a), Jan. 2, 2013, 126 Stat. 2215

    Source evidence

    Code source credit
    Aug. 1, 1946, ch. 724, title I, § 112, as added Pub. L. 112–239, div. C, title XXXI, § 3176(a), Jan. 2, 2013, 126 Stat. 2215

    Enacted provision · exact public law section
    (a) In General.— Chapter 10 of the Atomic Energy Act of 1954 (42 U.S.C. 2131 et seq.) is amended by adding at the end the following: “a. 42 USC 2142. The Commission may issue a license, or grant an amendment to an existing license, for the use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, only if, in addition to any other requirement of this Act— “(1) the Commission determines that— “(A) there is no alternative medical isotope production target that can be used in that reactor; and “(B) the proposed recipient of the medical isotope production target has provided assurances that, whenever an alternative medical isotope production target can be used in that reactor, it will use that alternative in lieu of highly enriched uranium; and “(2) the Secretary of Energy has certified that the United States Government is actively supporting the development of an alternative medical isotope production target that can be used in that reactor. “b. Definitions. As used in this section— “(1) the term ‘alternative medical isotope production target’ means a nuclear reactor target which is enriched to less than 20 percent of the isotope U–235; “(2) a target ‘can be used’ in a nuclear research or test reactor if— “(A) the target has been qualified by the Reduced Enrichment Research and Test Reactor Program of the Department of Energy; and “(B) use of the target will permit the large majority of ongoing and planned experiments and medical isotope production to be conducted in the reactor without a large percentage increase in the total cost of operating the reactor; “(3) the term ‘highly enriched uranium’ means uranium enriched to 20 percent or more in the isotope U–235; and “(4) the term ‘medical isotope’ includes molybdenum-99, iodine-131, xenon-133, and other radioactive materials used to produce a radiopharmaceutical for diagnostic or therapeutic procedures or for research and development.” .

  2. National Defense Authorization Act for Fiscal Year 2014

    Pub. L. 113–66 div. C title XXXI § 3144 · 127 Stat. 672

    Inserted · 42 U.S.C. § 2142

    Pub. L. 113–66 inserted section designation and catchline

    Source evidence

    Code amendment note
    Pub. L. 113–66 inserted section designation and catchline.

    Enacted provision · exact public law section
    SEC. 3144. TECHNICAL AMENDMENT TO ATOMIC ENERGY ACT OF 1954.   Chapter 10 of the Atomic Energy Act of 1954 (42 U.S.C. 2131 et seq.), as amended by section 3176 of the National Defense Authorization Act for Fiscal Year 2013 (Public Law 112–239; 126 Stat. 2215), 42 USC 2142. is amended in the matter following section 111 by inserting before “a. The Commission” the following: “Sec. 112. Domestic Medical Isotope Production.—”.

2 of 2 references resolved to an enrolled provision

Editorial Notes

References in Text

This chapter, referred to in subsec. (a), was in the original “this Act”, meaning act Aug. 1, 1946, ch. 724, as added by act Aug. 30, 1954, ch. 1073, § 1, 68 Stat. 919, known as the Atomic Energy Act of 1954, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 2011 of this title and Tables.

Amendments

2013—Pub. L. 113–66 inserted section designation and catchline.

Credits

1946–2013 · 2 acts
  1. 1946Aug. 1, 1946, ch. 724, title I, § 112, as added Pub. L. 112–239, div. C, title XXXI, § 3176(a), , 126 Stat. 2215
  2. 2013Pub. L. 113–66, div. C, title XXXI, § 3144, , 127 Stat. 1071.
Show as published

(Aug. 1, 1946, ch. 724, title I, § 112, as added Pub. L. 112–239, div. C, title XXXI, § 3176(a), , 126 Stat. 2215; Pub. L. 113–66, div. C, title XXXI, § 3144, , 127 Stat. 1071.)

Parsed from the official OLRC USLM XML in data/usc_all/usc42.xml · release point 119-108 · OLRC build 2026-09-09

USLM identifier /us/usc/t42/s2142